| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/24/2003 | WO2003106684A2 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | WO2003106674A2 Means and methods for regulating gene expression |
| 12/24/2003 | WO2003106673A1 Method of slective isolation or visualization of target cells differentiated from embryonic stem cells or kit for visualization |
| 12/24/2003 | WO2003106663A1 Primarily cultured adipocytes for gene therapy |
| 12/24/2003 | WO2003106662A1 In vitro fertilisation |
| 12/24/2003 | WO2003106661A2 Glutamine-free medium |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106658A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 12/24/2003 | WO2003106651A2 Spermatogonial cell line |
| 12/24/2003 | WO2003106645A2 Antisense modulation of smrt expression |
| 12/24/2003 | WO2003106640A2 Cell targeting methods and compositions |
| 12/24/2003 | WO2003106623A2 Early noninvasive prenatal test for aneuploidies and heritable conditions |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus |
| 12/24/2003 | WO2003106492A1 Marker for stem cells and its use |
| 12/24/2003 | WO2003106488A2 Novel antagonists of cxcr3-binding cxc chemokines |
| 12/24/2003 | WO2003106478A2 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 12/24/2003 | WO2003105887A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 12/24/2003 | WO2003105879A1 Compositions and methods for preventing, treating and diagnosing diabetes |
| 12/24/2003 | WO2003105874A1 Thymic epithelial cells with progenitor capacity |
| 12/24/2003 | WO2003105770A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/24/2003 | WO2003083136B1 Method and kit for detecting membrane protein-protein interactions |
| 12/24/2003 | WO2003083113A3 Growth regulating proteins |
| 12/24/2003 | WO2003083080A3 Mixed- cell gene therapy |
| 12/24/2003 | WO2003083071A3 Diabetes-related immunoglobulin derived proteins, compositions, methods and uses |
| 12/24/2003 | WO2003078585A3 Compositions and methods for primate neural cell production |
| 12/24/2003 | WO2003074721A3 Method for producing riboflavin |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003066832A3 Generation of new insulin cells from progenitor cells present in adult pancreatic islets |
| 12/24/2003 | WO2003064630A3 Cell culture medium |
| 12/24/2003 | WO2003060133A3 Selective plant growth using d-amino acids |
| 12/24/2003 | WO2003054210A3 Regulated nucleic acid expression system |
| 12/24/2003 | WO2003050272A3 Bone development model |
| 12/24/2003 | WO2003050251A3 Hematopoietic cells from human embryonic stem cells |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 12/24/2003 | WO2003022985A3 Method and structure for growing living organic tissue |
| 12/24/2003 | WO2003018626A3 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 12/24/2003 | WO2003011230A3 Modified reoviral therapy |
| 12/24/2003 | WO2003009857A8 Treatment of muscular dystrophy with cord blood cells |
| 12/24/2003 | WO2003000888A3 Method for separating bacterial cells and cell components |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002095014A3 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002081703A3 Mitogenic oxygenase regulators |
| 12/24/2003 | WO2002074969A3 Matrix attachment regions and methods for use thereof |
| 12/24/2003 | WO2002072831A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002061064A3 Method for producing recombinant trypsin |
| 12/24/2003 | WO2002057435A3 Bifunctional fusion proteins with glucocerebrosidase activity |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002026805A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/24/2003 | WO2001092542A8 Integrin-targeting vectors having enhanced transfection activity |
| 12/24/2003 | WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 12/24/2003 | WO2001058923A3 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 12/24/2003 | CN1462803A Technqiue for preapring small interfering expression vector of ribonucleic acid of mammal cell |
| 12/24/2003 | CN1462802A Method for preparing calmodulin combination type protein kinase gene and application in paddy |
| 12/24/2003 | CN1462749A Preparing anti-cancer active material in camptothecinum cell and method for restraining eancer cell |
| 12/24/2003 | CN1131663C Hypersensitive response induced resistance in plants |
| 12/24/2003 | CA2723500A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | CA2722998A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | CA2529724A1 In vitro fertilisation |
| 12/24/2003 | CA2495047A1 Methods and compositions for in vivo clearance of pathogens |
| 12/24/2003 | CA2490021A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 12/24/2003 | CA2489605A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | CA2489474A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2488924A1 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 12/24/2003 | CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/23/2003 | US6667426 Grapevine fanleaf virus resistance in grapevine expressing grapevine fanleaf virus coat protein |
| 12/23/2003 | US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| 12/23/2003 | US6667175 Allospecific human suppressor CD8+CD28- T cells. |
| 12/23/2003 | US6667163 Genetic engineering |
| 12/23/2003 | US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells. |
| 12/23/2003 | US6667049 Relic process for producing bioresorbable ceramic tissue scaffolds |
| 12/23/2003 | US6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | US6667034 Human gene therapy; culture product; adjustment of metabolism; regeneration bone marrow |
| 12/19/2003 | WO2002101076A2 Methods for targeted expression of therapeutic nucleic acid |
| 12/19/2003 | CA2460095A1 Methods for targeted expression of therapeutic nucleic acid |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104482A1 Signals and molecular species involved in senescence |
| 12/18/2003 | WO2003104476A2 Assay to detect replication competent viruses |
| 12/18/2003 | WO2003104470A2 Retrons for gene targeting |
| 12/18/2003 | WO2003104469A1 Adenovirus vector |
| 12/18/2003 | WO2003104456A1 Immunomodulation using altered dendritic cells |
| 12/18/2003 | WO2003104444A1 Generation of neural stem cells from undifferentiated human embryonic stem cells |
| 12/18/2003 | WO2003104443A2 Hair follicle mesenchymal stem cells and use thereof |
| 12/18/2003 | WO2003104442A1 Methods of regulating differentiation in stem cells |
| 12/18/2003 | WO2003104439A2 Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound |
| 12/18/2003 | WO2003104428A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 12/18/2003 | WO2003104423A2 Meningeal-derived stem cells |
| 12/18/2003 | WO2003104416A2 Spliceosome mediated rna trans-splicing in stem cells |